Categories AlphaGraphs, Earnings, Finance
Infographic: Highlights of Morgan Stanley (MS) Q3 2022 earnings report
Banking giant Morgan Stanley (NYSE: MS) on Friday y reported lower earnings and revenues for the third quarter of 2022. The company’s stock dropped soon after the announcement.
Net income applicable to shareholders was $2.63 billion or $1.47 per share in the third quarter of 2022, compared to $3.71 billion or $1.98 per share in the same period a year ago. Adjusted earnings dropped to $1.53 per share from $2.04 per share last year.
The bottom line was hurt by a 12% decrease in revenues to $12.9 billion. The company delivered ROTCE of 14.6%, or 15.2% excluding the impact of integration-related expenses.
Check this space to read management/analysts’ comments on Morgan Stanley’s Q3 2022 earnings
Shares of Morgan Stanley declined early Friday following the earnings announcement, after closing the last session higher.
Prior Performance
_________________________________________________________________________________________________________________
Stocks you may like:
_________________________________________________________________________________________________________________
Most Popular
Key takeaways from JM Smucker’s (SJM) Q4 2025 earnings report
Shares of The J.M. Smucker Co. (NYSE: SJM) plunged 15% on Tuesday after the company delivered mixed results for the fourth quarter of 2025. While earnings came ahead of expectations,
J.M. Smucker (SJM) Q4 2025 Earnings: Key financials and quarterly highlights
The J.M. Smucker Co. (NYSE: SJM) reported its fourth quarter 2025 earnings results today. Net sales was $2.1 billion, down 3% year-over-year. Comparable net sales decreased 1%. Net loss was
Plus Therapeutics CEO: Lead candidate REYOBIQ demonstrates strong safety and efficacy in early trials
Plus Therapeutics (NASDAQ: PSTV) is a pharmaceutical company engaged in the development of targeted radiotherapeutics for difficult-to-treat cancers. Currently, it is advancing a pipeline of product candidates with lead programs
